Greenland Mines Ltd Warrant (GRMLW) Stock Price, News & Analysis

Company Overview

Klotho Neurosciences is a clinical‐stage biotechnology company focused on developing innovative therapies that harness the neuroprotective and regenerative properties of the Klotho protein. The Klotho protein has been linked to neuronal health, longevity and resilience to various forms of cellular stress. By targeting pathways that increase or mimic Klotho activity in the central nervous system, the company aims to address a range of neurodegenerative and neuroinflammatory disorders.

The company’s pipeline includes both small-molecule candidates and engineered biologics designed to elevate Klotho levels in the brain or potentiate its signaling pathways. Preclinical studies conducted by Klotho Neurosciences have demonstrated efficacy in animal models of cognitive impairment and neuronal injury. The company is preparing to advance lead programs toward first-in-human trials, with a focus on conditions such as Alzheimer’s disease, Parkinson’s disease and other forms of dementia.

Founded in 2019, Klotho Neurosciences is headquartered in New York and maintains research collaborations with academic institutions and contract research organizations across North America and Europe. Its multidisciplinary team includes experts in protein engineering, medicinal chemistry and translational neuroscience, working together to accelerate the development of its novel therapeutic candidates.

Under the leadership of an experienced biotech management team, Klotho Neurosciences continues to broaden its scientific platform through strategic partnerships and funding initiatives. The company’s mission is to translate emerging insights from aging and longevity research into meaningful treatments for patients suffering from debilitating neurological diseases.

Key Stats

• Today's Range: $0.20 to $0.24
• 50-Day Range: $0.09 to $0.23
• 52-Week Range: $0.01 to $0.95
• Volume: 47,369 shs
• Average Volume: 13,484 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GRMLW Stock Analysis - Frequently Asked Questions

How have GRMLW shares performed this year?

Greenland Mines Ltd Warrant's stock was trading at $0.0959 on January 1st, 2026. Since then, GRMLW shares have increased by 106.6% and is now trading at $0.1981.

How do I buy shares of Greenland Mines Ltd Warrant?

Shares of GRMLW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:GRMLW
• Previous Symbol: NASDAQ:KLTOW
• CIK: 1907223
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A